| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |